Skip to content

Immunic, Inc.

IMUX· NasdaqCore metricsCIK 1280776

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -4.18%
Market cap
$123.87M
15.88M shares
Filings
837
$22.00K
Q1 2014
—
-$42.31M
Q3 2026N/M FY25 yoy
-$43.37M
Q3 2026N/M FY25 yoy
-$77.04M
Q3 2026derivedN/M FY25 yoy
-$0.99
Q3 2026N/M FY25 yoy
$131.96M
Q3 2026−56.6% FY25 yoy
$123.87M
—
—
1.2×
-69.40%
—

FY2025 figures · derived

Price

$7.80+900.26%+$7.02past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$22.00KQ1 2014
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

Immunic, Inc. is the 275th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR